See the factory by live video walkthrough
Book an on-site factory visit in GuangzhouAs the Modernization of Cosmetics Regulation Act (MoCRA) reshapes the U.S. cosmetics landscape, one of the most significant pending changes is the mandatory disclosure of fragrance allergens on product labels. While the FDA’s final…
As the Modernization of Cosmetics Regulation Act (MoCRA) reshapes the U.S. cosmetics landscape, one of the most significant pending changes is the mandatory disclosure of fragrance allergens on product labels. While the FDA’s final rule is still under development, early preparation is critical to avoid supply chain disruptions, costly reformulations, and compliance bottlenecks. This guide helps brand owners and sourcing managers take actionable steps now—before the rule arrives—to secure their label claims and supplier documentation.
MoCRA grants the FDA authority to require that cosmetic product labels list specific fragrance allergens when present above certain concentration thresholds. The agency intends to align its list with existing international frameworks, such as the EU Cosmetic Regulation (EC) No. 1223/2009, which currently identifies over 80 fragrance allergens. However, the U.S. approach may have distinct thresholds or a slightly condensed initial list. Brands must prepare for:
Waiting until the final rule is published could leave you scrambling for reformulations or force missed market windows. Implement these measures now to build a resilient compliance foundation.
Draft a procurement-ready document that asks for:
If any of your products contain EU-listed allergens above 0.001% (leave-on) or 0.01% (rinse-off), model scenarios where voluntary disclosure or a fragrance reformulation becomes necessary. This can shorten lead times by 8–12 weeks when the mandate hits.
Based on EU precedent and common industry use, the table below highlights fragrance materials that are likely to appear on the FDA’s initial list. Use this as a starting point for supplier conversations.
| Common Allergen | Typical Occurrence | Buyer Action Item |
|---|---|---|
| Limonene | Citrus fragrances, essential oils | Confirm purity and oxidation status via COA |
| Linalool | Floral and herbal notes | Request threshold verification from supplier |
| Citronellol | Rose, geranium, and citronella oils | Evaluate for leave-on vs. rinse-off limits |
| Geraniol | Palmarosa, rose, and citrus oils | Test for skin sensitization in final formula |
| Coumarin | Lavender, tonka bean, and sweetgrass | Check natural source documentation |
MoCRA emphasizes record maintenance and FDA access. A robust documentation pack should include:
The FDA has not yet set a definitive date, but the agency’s MoCRA implementation timeline suggests that proposed and final rules for fragrance allergens will emerge within the next 12–24 months. Brands should monitor the FDA’s Unified Agenda and start preparing now.
While the EU has a well-established list of 81 fragrance allergens (with disclosure required at 0.001% for leave-on and 0.01% for rinse-off products), the U.S. list may be shorter initially and could adopt different thresholds. However, because many fragrance suppliers are already EU-compliant, aligning with EU standards provides a strong head start for U.S. brands.
Yes. Under the anticipated rule, any allergen—whether intentionally added or present incidentally from a raw material—that exceeds the threshold must be declared. This includes contaminants, preservatives, or natural components that happen to be listed allergens.
Request a signed statement of composition that maps each component to the EU Annex III allergen list, with quantitative percentages. Also ask for recent analytical test reports (GC-MS or HPLC) demonstrating batch consistency. These documents will serve as your primary defense during an FDA inspection or label review.
Potentially, but caution is needed. “Unscented” products may still contain masking fragrances that include allergens, and “fragrance-free” claims require absolute proof of no added fragrance. Moreover, natural ingredients like plant extracts can introduce allergens unintentionally. Always verify with full disclosure from your formulator.
Navigating the upcoming fragrance allergen labeling requirements demands proactive supplier engagement and rigorous documentation. Don’t wait for the final rule to disrupt your time-to-market. At Laeyo Labs, our team can help you conduct a readiness audit, review supplier disclosures, and build a compliance strategy that protects your brand. Request a Quote today to start securing your fragrance supply chain for the MoCRA era.